Loading…
← CockpitCompetitor Analysis › 688212.SS Shanghai Aohua Photoelectricity Endoscope Co. Ltd. Class AOpen in the cockpit ↗

Shanghai Aohua Photoelectricity Endoscope Co. Ltd. Class A688212.SSCompetitor analysis, valuation and peers

China · CNY·Information Technology›Electronic Equipment/Instruments
Momentum neutral 59
Mkt cap
$518M
US dollars, full cap
Free float
58%
of shares outstanding
$/day
$10.4M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-3.2 pp
WACC 5.0%
Hurdle
n/a
no reverse DCF
Next earnings
148 days
15 Apr 2027
Close · CNYCN¥25.93
1D-0.3%
1W-8.0%
1M+1.6%
3M-16.8%
6M-27.5%
YTD-40.7%
1Y-44.3%
ATR %5.0%
52w lowhigh50.1% off high

What Shanghai Aohua Photoelectricity Endoscope does

Employees: 1,159

Shanghai Aohua Photoelectricity Endoscope at a glance

Size Shanghai Aohua Photoelectricity Endoscope (688212.SS) is a China Information Technology company (Electronic Equipment/Instruments) with a market value of $518M, the 3613th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥25.93 on 18 Nov 2026.

Performance Over six months the shares fell 27.5%, against -28.0% for the median peer and -20.0% for the China market (cap-weighted) — 11th highest of 21 in its peer set.

Growth Revenue grew 20.6% over the last twelve months (peer median +8.3%); the operating margin is -3.9% (peer median 1.3%).

Valuation It trades at 4.5× enterprise value to sales against a peer median of 4.1× (8th most expensive of 21).

Capital Return on invested capital runs 3.2 points below its cost of capital (5.0% WACC).

Next results Next results expected around 15 Apr 2027 (exchange calendar; dates can move).

Relative performance

70809010021 May 202621 Aug 202618 Nov 2026688212.SS 75Peer median 72
Six months, rebased to 100: Shanghai Aohua Photoelectricity Endoscope against the median of its 20 peers (local-currency closes).

Shanghai Aohua Photoelectricity Endoscope financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥806MCN¥771MCN¥744MCN¥672MCN¥442M
Revenue growth—+4%+11%+52%—
Gross profitCN¥563MCN¥441MCN¥452MCN¥453MCN¥275M
EBITDAn/aCN¥47.0MCN¥33.3MCN¥64.8MCN¥24.0M
Net income-CN¥30.3MCN¥11.5MCN¥21.0MCN¥57.9MCN¥21.7M
Free cash flow-CN¥158M-CN¥137M-CN¥252M-CN¥117M-CN¥115M
Capital expenditureCN¥80.7MCN¥130MCN¥187MCN¥158MCN¥78.8M
Total debtCN¥503MCN¥372MCN¥136MCN¥15.9MCN¥19.3M

Quarterly statements and history in the cockpit →

Shanghai Aohua Photoelectricity Endoscope competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%-20%-10%0%3001376166092870300349665260301569293013603008536885396859UMAC0021772439300354300445CAT300882002090002197688212.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Shanghai Aohua Photoelectricity Endoscope is the large dot.

Fundamentals: revenue growth against valuation

0%+100%+200%2.5×5×7.5×300137616609287030034966526030156929301360300853688539UMAC0021772439300354CAT300882002197688212.SSRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Shanghai Aohua Photoelectricity Endoscope is the large dot.

Shanghai Aohua Photoelectricity Endoscope competitors and peer comparison

How Shanghai Aohua Photoelectricity Endoscope compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Shanghai Aohua Photoelectricity Endoscope against its 20 peers (data as of 18 Nov 2026)
Measure688212.SSPeer medianRank in peer set
1-month return+1.6%-14.3%3rd highest of 21
6-month return-27.5%-28.0%11th highest of 21
Distance from 52-week high-50.1%-48.0%10th lowest of 21
Revenue growth (TTM)+20.6%+8.3%7th highest of 21
Operating margin-3.9%1.3%8th lowest of 21
EV / Sales4.5×4.1×8th most expensive of 21
ROIC minus cost of capital-3.2 pp-4.2 pp9th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Shanghai Aohua Photoelectricity Endoscope 688212.SSChina$518M-28%+21%-4%4.5×n/an/a
Hebei Sailhero Environmental Protection High-Tech 300137.SZChina$514M-65%-17%-13%4.3×n/an/a
Adlink Technology 6166.TWTaiwan$523M-25%+32%11%1.2×1.3%+4.1%
Exicon 092870.KSSouth Korea$508M+73%+273%11%6.7×n/an/a
Goldcard Smart 300349.SZChina$508M-41%-5%4%1.0×2.1%+10.8%
IDEC 6652.TJapan$529M-16%+20%12%1.0×-1.6%+6.2%
Ningbo Techmation 603015.SSChina$531M-30%+5%0%4.2×47.7%+2.0%
Nippon Ceramic 6929.TJapan$505M-23%-1%22%2.1×-3.2%+9.8%
Rongcheer Industrial Technology (Suzhou) 301360.SZChina$536M-24%+101%12%4.3×25.9%+11.7%
Hangzhou Shenhao Technology 300853.SZChina$500M-29%+125%-21%7.7×48.7%-12.4%
NanJing GOVA Technology 688539.SSChina$500M-52%-9%-18%8.2×n/an/a
Espec 6859.TJapan$499M+6%+8%10%0.9×7.5%+12.6%
Unusual Machines UMACUnited States$499M-33%+425%-76%5.5×n/an/a
Guangzhou KingTeller Technology 002177.SZChina$539M-39%-9%-17%65.4×n/an/a
Merry Electronics 2439.TWTaiwan$490M-19%+9%2%0.3×-5.2%+6.2%
Donghua Testing Technology 300354.SZChina$549M-30%-7%18%7.0×21.8%+20.9%
Beijing ConST Instruments Technology 300445.SZChina$486M-36%+7%19%4.0×7.5%+15.5%
Catapult Sports CAT.AXAustralia$557M-14%+14%-23%3.4×19.8%+18.0%
Zhejiang Wellsun Intelligent Technology 300882.SZChina$481M-38%+13%-1%2.1×n/an/a
Wiscom System 002090.SZChina$481M-27%-4%1%1.5×34.1%-3.4%
SZZT Electronics 002197.SZChina$560M-22%+39%-12%6.0×n/an/a

Questions

Which companies are Shanghai Aohua Photoelectricity Endoscope's closest peers?
The cockpit's peer set: Hebei Sailhero Environmental Protection High-Tech (300137.SZ), Adlink Technology (6166.TW), Exicon (092870.KS), Goldcard Smart (300349.SZ), IDEC (6652.T), Ningbo Techmation (603015.SS), Nippon Ceramic (6929.T), Rongcheer Industrial Technology (Suzhou) (301360.SZ).
Is Shanghai Aohua Photoelectricity Endoscope expensive compared with its peers?
On ev / sales it trades at 4.5× against a peer median of 4.1×, 8th most expensive of 21 in its peer set.
How has Shanghai Aohua Photoelectricity Endoscope stock performed?
Over six months to 18 Nov 2026 the shares returned -27.5% against -28.0% for the median peer; over one year -44.3%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.